:: Listing of publications from the BioInfoBank Library ::

Abmayr S and Chamberlain JS: The structure and function of dystrophin. In: Winder S (ed), The Molecular Mechanisms in Muscular Dystrophy (Georgetown: Landes Biosciences, 2005).

Chamberlain JS: Gene transfer to skeletal muscle. In: Danos O, (ed), Encyclopedia of Genetics, Genomics, Proteomics and Bioinformatics (Chichester: John Wiley & Sons, 2005).

Weisbart RH, Nishimura R, Hansen JE, Chan G, Wakelin R, Chang S, Baresi L, and Chamberlain JS: An intracellular delivery vehicle for protein transduction of micro-dystrophin. J Drug Target 2005; 13:81-87.

Li S, Kimura E, Reyes M, Angello JC, Welikson R, Hauschka SD and Chamberlain JS: Stable transduction of myogenic cells with lentiviral vectors expressing a mini-dystrophin. Gene Therapy, 2005; 12: 1099-1108.

Balcaitis S, Weinstein JR, Li S, Chamberlain JS, Moller T. Lentiviral transduction of microglial cells. Glia 2005 Dec 29.

Liu M, Yue Y, Harper SQ, Grange RW, Chamberlain JS and Duan D: Adeno-associated virus-mediated micro-dystrophin expression protects young mdx muscle from contraction-induced injury. Mol Ther 2005; 11:245-256.

Chamberlain, J: PCR-mediated mutagenesis. In: Nature Encyclopedia of Life Sciences. (London: Nature Publishing Group, 2004).

Gregorevic P, Blankinship MJ, Chamberlain JS. Viral vectors for gene transfer to striated muscle. Curr Opin Mol Ther 2004 Oct; 6(5):491-8.

Blankinship MJ, Gregorevic P, Allen JM, Harper SQ, Harper H, Halbert CL, Miller DA, Chamberlain JS. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol Ther 2004 Oct; 10(4):671-8.

Gregorevic P, Blankinship MJ, Allen JM, Crawford RW, Meuse L, Miller DG, Russell DW, Chamberlain JS. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 2004 Aug; 10(8):828-34. E-pub 2004, Jul 25.

Bachrach E, Li S, et al. (2004) Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells. Proc Natl Acad Sci USA 101(10):3581-6.

Ge Y, Molloy MP, Chamberlain JS, Andrews PC. Differential expression of the skeletal muscle proteome in mdx mice at different ages. Electrophoresis 2004
Aug 25(15):2576-85.

Li S, Kimura E, Fall BM, et al. (2004) Stable transduction of myogenic cells with lentiviral vectors expressing a mini-dystrophin. Gene Therapy, in press.

Abmayr S, Crawford R and Chamberlain JS: Characterization of ARC, apoptosis repressor interacting with CARD, in normal and dystrophin-deficient skeletal muscle. Hum Molec Genet 2004; 13:213-221.

Friedrich O, Both M, Gillis JM, Chamberlain JS, Fink RH. Mini-dystrophin restores L-type calcium currents in skeletal muscle of transgenic mdx mice. J Physiol 2004 Feb 15; 555(Pt 1):251-65. E-pub 2003, Oct 31.

Ge Y, Molloy MP, Chamberlain JS, Andrews PC. Proteomic analysis of mdx skeletal muscle: Great reduction of adenylate kinase 1 expression and enzymatic activity.
Proteomics 2003 Oct; 3(10):1895-903.

Yue Y, Li Z, Harper SQ, Davisson RL, Chamberlain JS, Duan D. Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation 2003 Sep 30; 108(13):1626-32. E-pub 2003, Sep 02.

Chamberlain JS: Gene therapy of muscular dystrophy. Hum Mol Genet 2002; 11:2355-2362

Scott JM, Li S, et al. (2002) Viral vectors for gene transfer of micro-, mini-, or full-length dystrophin. Neuromuscular Disorders 12 Suppl 1:S23-9.

Gregorevic P, Chamberlain JS. Gene therapy for muscular dystrophy - a review of promising progress. Expert Opin Biol Ther 2003 Aug; 3(5):803-14. (Review)

Barjot C, Hartigan-O'Connor D, Salvatori G, Scott JM, and Chamberlain JS: Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses. J Gene Med 2002, 4:480-489.

DelloRusso C, Scott J, Hartigan-O'Connor D, Salvatori G, Barjot C, Robinson AS, Crawford RW, Brooks SV, and Chamberlain JS: Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. Proc Nat'l Acad Sci 2002; 99:12979-12984.

Hartigan-O'Connor D, Barjot C, Salvatori G, and Chamberlain JS: Generation and growth of gutted adenoviral vectors. Methods Enzymol 2002; 346:224-246.

Harper S, Hauser M, DelloRusso C, Duan D, Crawford RW, Phelps SF, Harper HA, Robinson AS, Engelhardt JF, Brooks SV, and Chamberlain JS. Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy. Nature Med 2002; 8:253-261.

Warner L, DelloRusso C, Crawford R, Rybakova I, Patel I, Ervasti J, and Chamberlain JS. Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex. Hum Mol Genet 2002; 11:1095-1105.

Kimura E, Maeda Y, Arima T, Nishida Y, Yamashita S, et al. Efficient repetitive gene delivery to skeletal muscle using recombinant adenovirus vector containing the Coxsackievirus and adenovirus receptor cDNA. Gene Ther, 2001 8(1): 20-27.

In Press / Submitted

Chamberlain JS and Rando T, eds: Duchenne Muscular Dystrophy: Advances in Therapeutics. (New York: Taylor and Francis, Inc., 2005), in press.

Blankinship M, Gregorevic P and Chamberlain JS: Adeno-associated viral vectors for gene therapy of DMD. In: Chamberlain JS and Rando T, (eds): Duchenne Muscular Dystrophy: Advances in Therapeutics. (New York: Taylor and Francis, Inc., 2006), in press.

Lai Y, Yue Y, Liu M, Ghosh A, Engelhardt JF, Chamberlain JS, Duan D: Rescue of muscular dystrophy in mdx mice by trans-splicing adeno-associated virus-mediated DH2-R19 mini-dystrophin expression. Nat Biotech 2005; in press.

Reyes M, Li S, Kimura E, and Chamberlain JS: Donor origin of Multipotent Adult Progenitor Cells in radiation chimeras. Blood 2005; in press.

Gregorevic P and Chamberlain JS: Functional enhancement of skeletal muscle by gene transfer. Phys Med Rehabil Clin N Am 2005; in press.

Han JJ, Ra JJ, Abresch RT, Robinson LR Chamberlain JS and Carter GT: Electromyographic (EMG) studies in mdx and wild type mice. Muscle Nerve 2005; in press.

Abmayr S, Gregorevic P, Allen JM and Chamberlain JS: Enhanced muscle recovery following co-delivery of micro-dystrophin and Igf-1 to adult mdx muscles. Mol Ther 2005; in press.

Abmayr S, Gregorevic P, Allen JM, Chamberlain JS. Phenotypic improvement of dystrophic muscles by rAAV/micro-dystrophin vectors is augmented by Igf-1 co-delivery. Mol. Ther: submitted.

Uchida Y, Maeda Y, Kimura E, Yamashita S, Nishida Y, et al. Effective repetitive dystrophin gene transfer to adult mdx mouse muscle using helper-dependent adenoviral vector expressing full-length dystrophin and the primary adenovirus receptor (CAR) J Gene Med, in press.

Li, S., Kimura, E, Fall, BM, et al. Stable transduction of myogenic cells with lentiviral vectors expressing a mini-dystrophin. Gene Therapy, in press.